OBiO Tech

Established in 2013, OBiO Technology leads the way in gene and cell therapy as a pioneering CRO and CDMO. Our expertise spans vectorology studies, functional genomics, PD, AD, GMP production, as well as IND-enabling CMC and clinical and commercial manufacturing, provides comprehensive solutions internationally and tailored services for your needs. 🧬 GMP production: State-of-the-art 77,000 m2(830,000 ft 2) facility for global supply. 🧬 We specialize in vectorology studies, functional genomics, PD and AD, ensuring Investigational New Drug (IND) readiness and supporting all phases of clinical and commercial manufacturing. 🧬 From laboratory to clinic, we continuously advance your products, positively impacting populations worldwide. 🧬 Our unwavering commitment ensures the delivery of high quality CDMO services across the preclinical, IND, clinical, and commercial stages. 🧬Our expertise spans plasmids, mRNA, AAV, LVV, Ad viral vectors, cell therapy, CAR-T, NK, Treg, iPSCs, Exosome ...Oncolytic virus, as well as cutting-edge technologies like inducible viral vector packaging, ultralow endotoxin processes, and AAVneo for tissue-specific AAV variants, etc. 🧬Trustful Expertise: 10+ years experience in Cell & Gene Therapy, over 40% master degree above holders. ❓Do not hesitate to send an inquiry or question here: https://lnkd.in/g8BzXQfQ 📞Phone: ++1 781-748-4204 (U.S.) 📭Email: oobio@obiosh.com